Point72 Asset Management L.P. 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:18 pm Sale | 2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Point72 Asset Management L.P. | 913,242 1.300% | -719,962 (-44.08%) | Filing |
| 2022-02-14 4:38 pm Purchase | 2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Point72 Asset Management L.P. | 1,633,204 5.800% | 132,961 (+8.86%) | Filing |
| 2021-11-17 5:27 pm Purchase | 2021-11-09 | 13G | X4 Pharmaceuticals, Inc. XFOR | Point72 Asset Management L.P. | 1,500,243 5.600% | 1,500,243 (New Position) | Filing |